Anhui Poly, a wholly-owned subsidiary of Hainan Poly Pharm. Co., Ltd (hereinafter referred to as "the Company"), has recently received the “the Notice of Drug GMP Compliance Inspection Results" (hereinafter referred to as "the Notice") issued by Anhui Center for Drug Evaluation, the product involved is: API (Gadoterate meglumine).
Poly Pharm. has successfully developed Salidroside (Scientific name 2-(4-hydroxyphenyl) ethyl-β-D-glucopyranoside), a raw material for drugs, cosmetics and health care products, through synthetic biology technology. The product is obtained by fermentation of genetically engineered strains of bacteria, and the purity reaches more than 98%.
